Market Mechanics Update: Navigating the New Closing Auction Session (CAS)

By | July 31, 2026 8:02 pm

Market structure changes dictate execution strategy. The exchange has fundamentally altered the end-of-day trading mechanics for specific equities, shifting from standard continuous matching up to 3:30 PM to a structured Closing Auction Session (CAS). For active traders, understanding these micro-structural changes is critical. If you are trading CAS-eligible stocks, the traditional rules of engagement in… Read More »

From Tenants to True Family – A Heart-Wrenching Story of Love, Loss, and Belonging

By | July 31, 2026 1:53 pm

It was the season’s first torrential downpour. The streets had turned into rivulets, and the relentless rain blurred the world into a hazy watercolor painting. Standing drenched in that merciless rain, outside a modest, unassuming house, was a newlywed bride clutching her dripping dupatta, her teeth chattering slightly. “Is… is this the place?” Riddhima asked, her… Read More »

Glenmark Pharmaceuticals Ltd (GLENMARK) – Q1 FY2026-27 Results Analysis

By | July 31, 2026 1:09 pm

Executive Summary: The Headline Strong recovery quarter: Consolidated Revenue +23% YoY to ₹4,018 Cr. PAT surged to ₹483 Cr (vs ₹47 Cr YoY — multi-fold jump). EBITDA +39% YoY to ₹805 Cr with margin expansion to 20%. Broad-based growth: India Formulations +15.5%, North America and Europe also contributed positively. Overarching narrative: Glenmark delivered a robust… Read More »

Sun Pharmaceutical Industries Ltd (SUNPHARMA) – Q1 FY2026-27 Results Analysis

By | July 31, 2026 10:34 am

Executive Summary: The Headline Solid top-line and reported profit growth: Revenue +10.5% YoY to ₹15,300 Cr. Reported PAT +27% YoY to ₹2,895 Cr. Adjusted PAT +3.1% to ₹3,089 Cr. India and Specialty drove performance: India Formulations grew 16% YoY. Global Innovative Medicines grew 12.8%. US Formulations declined. Overarching narrative: A steady quarter for India’s largest… Read More »

GAIL (India) Ltd – Q1 FY2026-27 Results Analysis

By | July 31, 2026 9:27 am

Executive Summary: The Headline Exceptional profitability surge: Consolidated PAT nearly doubled (+97% YoY) to ₹4,665–4,671 Cr. Revenue +17% YoY to ₹41,350 Cr. Gas Marketing drove the beat: Natural Gas Marketing PBIT more than tripled, becoming the primary earnings engine. Transmission remained stable, while Petrochemicals stayed weak. Overarching narrative: A strong quarter for GAIL, powered by… Read More »

Monthly Closing Day: FIIs Unleash ₹3,600Cr in Cash & Cover Shorts Ahead of Huge Gann/Astro Breakout

By | July 31, 2026 9:04 am

Market Date Analysis: July 30, 2026Nifty 50 CMP (Closing Price): 24,296 The expiry is behind us, and we are now stepping into the new series with a massively important trading session. Today is all about the Weekly and Monthly Close, and it has the power to dictate the structural market trend for the entirety of August. While yesterday’s… Read More »

Bank Nifty Trading Plan: Monthly Inside Bar, Bayer Rule 15, and Key Levels to Watch

By | July 31, 2026 8:43 am

As we head into the high-stakes monthly expiry session, Bank Nifty is displaying classic signs of a coiled spring. Yesterday’s session saw tight consolidation, closing merely 49 points lower inside a 425-point daily range. The advance/decline breadth was exceptionally weak (03:11), but looking at the bigger macro picture and underlying derivative positions, an aggressive directional move is… Read More »

Exide Industries Ltd (EXIDEIND) – Q1 FY2026-27 Results Analysis

By | July 30, 2026 11:09 pm

Executive Summary: The Headline Healthy double-digit growth: Revenue +18% YoY to ₹5,528 Cr. PAT +28% YoY to ₹351 Cr. EBITDA +15.5% YoY to ₹621 Cr. Broad-based strength: Automotive OEM business grew >25% for the third consecutive quarter. Replacement, Industrial, Inverter, and Solar segments also delivered double-digit growth. Overarching narrative: A solid start to FY27 for… Read More »

Mahindra & Mahindra Ltd (M&M) – Q1 FY2026-27 Results Analysis

By | July 30, 2026 11:08 pm

Executive Summary: The Headline Strong broad-based growth: Consolidated Revenue +28% YoY to ₹58,188 Cr. PAT +34% YoY to ₹5,455 Cr. Leadership retained: #1 in SUVs (25% revenue market share), #1 in Tractors (44.9% market share), and strong performance in LCVs and electric 3-wheelers. Overarching narrative: An excellent start to FY27. M&M delivered robust growth across… Read More »

Bajaj Finance Ltd (BAJFINANCE) – Q1 FY2026-27 Results Analysis

By | July 30, 2026 11:07 pm

Executive Summary: The Headline Strong all-round performance: Consolidated PAT +27–28% YoY to ₹5,986–6,081 Cr. NII +23% YoY to ₹12,571 Cr. AUM +24% YoY to ₹5.47 Lakh Cr. Healthy franchise growth: 16.13 million new loans booked (+20% YoY). Customer franchise crossed 124 million. Overarching narrative: Bajaj Finance delivered another high-quality quarter with robust AUM growth, improving… Read More »